Asia Pacific Veterinary Medicine Market Size & Outlook
Global Market
Related Markets
Asia Pacific veterinary medicine market highlights
- The Asia Pacific veterinary medicine market generated a revenue of USD 11,441.6 million in 2025.
- The market is expected to grow at a CAGR of 11% from 2026 to 2033.
- In terms of segment, pharmaceuticals was the largest revenue generating product in 2025.
- Biologics is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 11,441.6 million |
| Market revenue in 2033 | USD 26,007.9 million |
| Growth rate | 11% (CAGR from 2026 to 2033) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Biologics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
| Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.2% of the global veterinary medicine market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 26,007.9 million by 2033.
The Asia Pacific market is expected to exhibit lucrative growth over the forecast period. This can be attributed to the increasing adoption of pet animals, growing health concerns, increasing vigilance about animal health, rising livestock population, and increasing prevalence of animal diseases.
Moreover, market growth in the region can be attributed to a significantly large cattle population. For instance, China & India constitute more than 30% of the global population of cattle. The large livestock population has enhanced the demand for meat & dairy production, which is expected to further boost the demand for veterinary medicines for livestock animals.
An increase in the number of veterinary hospitals and clinics in countries such as China is further boosting market growth. The region has a wide number of market players. These market players are involved in strategic partnerships, expansions, product launches, and others to cater to market demand.
No credit card required*
Publish Date: Apr 06, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Veterinary Medicine Market Scope
Veterinary Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Virbac SA | View profile | 5,400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | www.virbac.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Elanco Animal Health Inc | View profile | 9,800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | www.elanco.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Dechra Pharmaceuticals | View profile | 501-1000 | Northwich, Cheshire, United Kingdom, Europe | www.dechra.com |
| Ceva Santé Animale | View profile | 5001-10000 | Libourne, Aquitaine, France, Europe | www.ceva.us |
| Phibro Animal Health Corp Class A | View profile | 1,920 | 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 | www.pahc.com |
| Biogenesis Bago | View profile | 501-1000 | Garín, Buenos Aires, Argentina, South America | www.biogenesisbago.com/en/ |
| Bimeda Ireland | View profile | 1001-5000 | Tallaght, Dublin, Ireland, Europe | www.bimeda.ie/ |
Asia Pacific Veterinary Medicine Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Medicine Market Outlook will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 63.98% in 2025.
Horizon Databook has segmented the Asia Pacific veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2021 to 2033.
The Asia Pacific market is expected to exhibit lucrative growth over the forecast period. This can be attributed to the increasing adoption of pet animals, growing health concerns, increasing vigilance about animal health, rising livestock population, and increasing prevalence of animal diseases.
Moreover, market growth in the region can be attributed to a significantly large cattle population. For instance, China & India constitute more than 30% of the global population of cattle. The large livestock population has enhanced the demand for meat & dairy production, which is expected to further boost the demand for veterinary medicines for livestock animals.
An increase in the number of veterinary hospitals and clinics in countries such as China is further boosting market growth. The region has a wide number of market players. These market players are involved in strategic partnerships, expansions, product launches, and others to cater to market demand.
- Asia Pacific Veterinary Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
- Biologics
- Pharmaceuticals
- Medicated Feed Additives
- Asia Pacific Veterinary Medicine Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
- Companion Animals
- Production Animals
- Asia Pacific Veterinary Medicine Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
- Oral
- Other Routes
- Injectable
- Topical
- Asia Pacific Veterinary Medicine Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- E-commerce
- Offline Retail Stores
- Others
- Veterinary Hospitals & Clinics
Reasons to subscribe to Veterinary Medicine Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Medicine Market Outlook databook
- Our clientele includes a mix of Veterinary Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Veterinary Medicine Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Veterinary Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Veterinary Medicine Market, 2021-2033 (US$M)
Asia Pacific veterinary medicine market statistics, by product, 2021-2033 (US$M)
